XP CHEMISTRIES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.099 SEK | -16.10% |
|
-10.81% | -16.81% |
| 05-17 | XP Chemistries AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-22 | XP Chemistries AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 1.06M 100K 138K | Sales 2023 | 664K 63.16K 86.77K | Capitalization | 11.12M 1.06M 1.45M |
|---|---|---|---|---|---|
| Net income 2022 | -7M -666K -915K | Net income 2023 | -8M -761K -1.05M | EV / Sales 2022 | 0.87 x |
| Net cash position 2022 | 15.2M 1.45M 1.99M | Net cash position 2023 | 7.83M 745K 1.02M | EV / Sales 2023 | 4.96 x |
| P/E ratio 2022 |
-1.74
x | P/E ratio 2023 |
-0.46
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.82% |
More Fundamentals
* Assessed data
More news
| 1 day | -16.10% | ||
| 1 week | -10.81% | ||
| Current month | -17.50% | ||
| 1 month | +73.68% | ||
| 3 months | +160.53% | ||
| 6 months | -23.85% | ||
| Current year | -16.81% |
1 week
0.09
0.19
1 month
0.060.21
Current year
0.030.21
1 year
0.030.65
3 years
0.034.50
5 years
0.034.50
10 years
0.034.50
| Managers | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 41 | 20-12-31 |
Anders Frejdh
DFI | Director of Finance/CFO | 50 | 20-12-31 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Armando Córdova
FOU | Founder | 54 | 14-12-31 |
Jonas Hafrén
BRD | Director/Board Member | 55 | 20-12-31 |
Samson Afewerki
FOU | Founder | 39 | 14-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-14 | 0.099 | -16.10% | 714,789 |
| 24-06-13 | 0.118 | -9.23% | 824,794 |
| 24-06-12 | 0.13 | -15.03% | 858,087 |
| 24-06-11 | 0.153 | +51.49% | 5,419,800 |
| 24-06-10 | 0.101 | -9.01% | 111,357 |
Delayed Quote Nasdaq Stockholm, June 14, 2024 at 12:00 pm
More quotes
XP Chemistries AB is a Sweden-based chemical, biological and pharmaceutical manufacturer. The Company has an international patent portfolio covering sustainable nature-inspired technologies optimal combinations of catalytic processes for the production of bio-based chemicals.
Sector
Pharmaceuticals
Calendar
2024-08-18
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.81% | 878K | |
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
- Stock Market
- Equities
- XPC Stock
